# XOMA Royalty share price (XOMA Royalty Corporation, XOMA)

> XOMA Royalty Corporation's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. XOMA · Healthcare · Biotechnology · data as of 13 July 2026. Page: https://www.sectoralpha.in/us/stocks/xoma

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Price: $40.17 (+48.0% in a year)
- P/E: 25.5× (lower than 55% of the last 4.3 years)
- Revenue (Jun 2026): $17.0 M (+29.5% on a year ago)
- Profit (Jun 2026), incl. one-off: −$43.3 M (one-off item, see below)
- Operating margin: −125.4% (−160.5 points on a year ago)
- ROE: 18%, FY25
- ROIC: 3.3%, against a 9.2% cost of capital: −5.9 points
- Profit that came in as cash: 97%, last 2 years

Biggest thing to watch: the price has already been rising for 17 weeks, so timing is the risk more than the business. ## What is the XOMA Royalty share price? XOMA Royalty Corporation's share price was $40.17 at the close on 13 July 2026. It has been rising for 17 weeks. That is 19.2% above its average price over the last 200 trading days. In the last 52 weeks it traded between $24 and $44, and at that close it sat 80% of the way up from that low. Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 1 week running. Over the last 10 years the share price moved +266% while the S&P 500 moved +255%, so it is ahead of the index over that whole period. It was last ahead over 13 weeks in the week of 10 July 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does XOMA Royalty pay? XOMA Royalty Corporation pays no dividend. In the last 12 reported quarters it declared no dividend per share, so there is no payout history to chart and no yield to show. Companies like this usually keep their earnings in the business, so the cash-flow sections show where that cash goes. ## Which stock lists is XOMA Royalty on? XOMA Royalty is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is XOMA Royalty profitable? XOMA Royalty Corporation posted a net loss of $43.3 M in the Jun 2026 quarter. That quarter includes a one-off gain bigger than its revenue, so the comparison with last year does not reflect normal business. Full-year FY25 profit was $18.5 M. Over 4 years profit has grown 24.2% a year on average. That loss is 254.7% of the quarter's revenue. The same quarter a year earlier earned $5.5 M. 6 of the last 12 reported quarters were loss-making. Jun 2026 profit was −$43.3 M, −884.2% on a year earlier. Read this profit with care: at −$43.3 M it is bigger than the quarter's whole revenue of $17.0 M. No business earns more than it takes in from sales, so this is a one-off item (for example a debt settlement, a tax write-back or an asset sale), not money the business earned. The underlying business is running at a −125.4% operating margin. The jump on last year, and any P/E built on this profit, come from the one-off, not from a real turn in earnings. ## How much revenue does XOMA Royalty make, and is it growing? XOMA Royalty Corporation reported $17.0 M of revenue in the Jun 2026 quarter, +29.5% on the same quarter a year earlier. Over 4 years it has grown 8.1% a year on average. The last full year, FY25, came in at $52.1 M. The last four reported quarters add to $52.4 M. FY25 revenue was $52.1 M, +83.1% on the year before. Recent pace: the last four quarters grew +23.7% on average, against 8.1% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +16.6%, against +85.5% a year over the last 8 quarters (rolling over). ## How much of every $100 of sales does XOMA Royalty keep? XOMA Royalty Corporation's operating margin was −125.4% in the Jun 2026 quarter, 160.5 percentage points lower than the same quarter a year ago. Across 5 years it has been between −493.1% and 45.9%. The latest quarter is within that range. Why the margin moved: operating margin changed −160.5 percentage points on the year while gross margin changed +0.8 points. So the drop came mostly from costs below the gross margin, such as staff and overheads, measured against sales. ## Is XOMA Royalty's profit turning into cash? Over the last 2 years, 97% of XOMA Royalty Corporation's reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in $2.9 M of operating cash against $18.5 M of profit. After null of spending on assets, $2.9 M was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does XOMA Royalty's cash go? XOMA Royalty Corporation does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $37.0 K on assets over the last 2 years. Averaged over those years that is 0.0% of FY25 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $37.0 K over the last 2 years. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is XOMA Royalty's P/E ratio, and how does it compare with its own history? XOMA Royalty Corporation's P/E is 25.5×, in the middle of its own history: higher than 45% of past readings. Its usual P/E (the middle reading) is 26.1×, over 4.3 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Where the price move came from: over 3 years the price moved +34.4% a year; about +27.9% a year came from earnings growth and about +6.5 percentage points from the multiple (the market paying more). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is about average against its own past, so the earnings trend underneath matters more than the multiple. ## Is the XOMA Royalty business getting better or worse? XOMA Royalty Corporation's business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 12 quarters of 2 measures, with some gaps. Why it matters: with too little history, we say so rather than guess a direction. The latest quarter’s profit includes a one-off item bigger than the normal business, so the profit line is shown but does not count in this reading. One or more growth lines have an extreme jump caused by comparing with a near-zero or loss-making quarter. Those jumps are capped before reading and drawn at the edge of the chart, so one odd quarter does not decide the result. There are fewer than eight usable quarters, so this page does not guess a direction from so little history. ## How much does XOMA Royalty earn on its capital? XOMA Royalty Corporation earned a ROE of 18% in FY25. That is up from a low of −52% in FY23. Its return on capital used (ROIC) is 5.9 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a 35.5% net margin and 0.19× asset turnover (sales divided by assets). Why the return is what it is (FY25): a 35.5% net margin × 0.19× asset turnover × 2.62× leverage (assets divided by equity) ≈ 17.7% on equity. The margin does most of the work; borrowing is a big part of it. The key test, return on capital used minus the cost of capital: 3.3% − 9.2% = −5.9 percentage points. The 9.2% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. The 3.3% ROIC above is the latest reading, as reported. The yearly chart below shows FY25 at 9.1%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does XOMA Royalty have too much debt? XOMA Royalty Corporation has total debt of $124 M against shareholder equity of $87.3 M as of Jun 2026, so its debt is 1.42× its equity. Year by year, that ratio went from 0.00 in FY21 to 1.27 in FY25. Keep that borrowing in mind when reading the returns on this page. ## What is the XOMA Royalty shareholding pattern? 13.5% of XOMA Royalty Corporation's tradable shares are in short positions, which are bets that the price will fall, so a large group of traders is betting against it. At normal trading volumes, closing those positions would take about 6.4 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is XOMA Royalty from balance-sheet trouble? For XOMA Royalty Corporation, the Z-score is −4.35. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is in the danger zone. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of −4.35 is inside the danger zone, so the balance sheet is a real risk. ## How does XOMA Royalty rank in its industry? There is no score against its industry: XOMA Royalty Corporation is not among the largest members shown in this industry comparison for Biotechnology. The score ranks a company within its industry: each measure is scored against the other members. Without that group there is no score, so none is shown. ## Which companies is XOMA Royalty compared with? No sector comparison is shown here, not among the largest members shown in this industry comparison. ## Which companies are close to XOMA Royalty in size? XOMA Royalty is the 124th largest of 211 Biotechnology companies on Sector Alpha by market value (scores of 5 November 2026). Just above it: Ginkgo Bioworks Holdings, Inc., OmniAb, Inc. and Wave Life Sciences. Just below it: Solid Biosciences Inc., Geron Corporation and Candel Therapeutics, Inc. ### Biotechnology companies close in size

1. [Ginkgo Bioworks Holdings, Inc.](https://www.sectoralpha.in/us/stocks/dna) $785 million
2. [OmniAb, Inc.](https://www.sectoralpha.in/us/stocks/oabi) $756 million
3. [Wave Life Sciences Ltd.](https://www.sectoralpha.in/us/stocks/wve) $714 million
4. XOMA Royalty Corporation $710 million
5. [Solid Biosciences Inc.](https://www.sectoralpha.in/us/stocks/sldb) $699 million
6. [Geron Corporation](https://www.sectoralpha.in/us/stocks/gern) $694 million
7. [Candel Therapeutics, Inc.](https://www.sectoralpha.in/us/stocks/cadl) $692 million

[All 211 Biotechnology companies, largest first](https://www.sectoralpha.in/us/sectors/biotechnology#all-companies)

### Companies close in size in other industries

1. [Bar Harbor Bankshares](https://www.sectoralpha.in/us/stocks/bhb) $713 million · Banks - Regional
2. [Empresa Distribuidora y Comercializadora Norte Sociedad Anónima](https://www.sectoralpha.in/us/stocks/edn) $712 million · Utilities - Regulated Electric
3. XOMA Royalty Corporation $710 million
4. [California BanCorp](https://www.sectoralpha.in/us/stocks/bcal) $709 million · Banks - Regional
5. [Donegal Group Inc.](https://www.sectoralpha.in/us/stocks/dgica) $709 million · Insurance - Property & Casualty

## What else do people ask about XOMA Royalty? ### What were XOMA Royalty's latest quarterly results? XOMA Royalty Corporation reported revenue of $17.0 M and a net loss of $43.3 M for the Jun 2026 quarter. Revenue rose 29.5% and profit fell 884.2% compared with a year earlier. Earnings per share were −$2.49. The operating margin was −125.4%, 160.5 percentage points lower than a year earlier (as of 13 July 2026). ### What is XOMA Royalty's market cap? XOMA Royalty Corporation's market capitalisation is $710 M at a stock price of $40.17. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 13 July 2026). ### How is XOMA Royalty performing? XOMA Royalty Corporation's share price has been rising for 17 weeks. In its latest quarter, revenue rose 29.5% and profit fell 884.2% compared with a year earlier. Over the past 13 weeks it has done worse than the S&P 500, for 1 week running (as of 13 July 2026). ### Will XOMA Royalty's stock price go up? This page does not forecast XOMA Royalty Corporation's stock price. What it shows instead: the stock price is $40.17, and it has been rising for 17 weeks. Its P/E of 25.5× is higher than 45% of its own last 4 years (as of 13 July 2026). ### Does XOMA Royalty have too much debt? Yes, XOMA Royalty Corporation has a lot of debt: its debt is 1.10× its equity. A year-by-year history of its borrowings is not in our data, so this uses the latest reading. Keep that borrowing in mind when reading the returns on this page (as of 13 July 2026). ### Is XOMA Royalty's profit real cash? Yes, over the last 2 years, 97% of XOMA Royalty Corporation's reported profit came in as cash from operations. The latest year was lower at 16%, so the trend is worth watching. In FY25, operating cash was $2.9 M against reported profit of $18.5 M. Most of that cash then goes into building new capacity. These are yearly figures (as of 13 July 2026). ### Where is XOMA Royalty in its business cycle? XOMA Royalty Corporation's FY25 operating margin was 21.8%, against a 5-year range of −493.1% to 45.9%: the middle of its own range, neither a peak nor a low. The latest quarter was −125.4%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 13 July 2026). ### What could break the XOMA Royalty story? Biggest thing to watch: the price has already been rising for 17 weeks, so timing is the risk more than the business. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 13 July 2026). ### Is XOMA Royalty a stock worth studying right now? What the numbers show: XOMA Royalty Corporation's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: the next one or two quarters of results. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 13 July 2026). This is research, not advice. We’re not SEBI-registered.